INDIAN - IRESSA 250mg (30 tablets) - Each tablet contains Gefitinib 250mg.
Gefitinib inhibits the intracellular phosphorylation of numerous tyrosine kinases associated with transmembrane cell surface receptors, including the tyrosine kinases associated with the epidermal growth factor receptor (EGFR-TK). EGFR is expressed on the cell surface of many normal cells and cancer cells.
GEFTINAT (Gefitinib) is indicated as monotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.
The recommended daily dose of GEFTINIB in one 250mg tablet with or without food. Higher doses do not give a better response and may cause increased toxicity. It is advisable to consult your doctor to prescribe the dosage that suits your condition.
SEND INQUIRY
Please fill in fully your information to send email